Critical Contrast: SMX (Security Matters) Public (NASDAQ:SMX) versus Mirion Technologies (NYSE:MIR)

SMX (Security Matters) Public (NASDAQ:SMX) and Mirion Technologies (NYSE:MIR) are both business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

Profitability

This table compares SMX (Security Matters) Public and Mirion Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SMX (Security Matters) Public	N/A	N/A	N/A
Mirion Technologies	3.11%	6.97%	3.85%

Earnings and Valuation

This table compares SMX (Security Matters) Public and Mirion Technologies”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SMX (Security Matters) Public	N/A	N/A	-$169.18 million	N/A	N/A
Mirion Technologies	$925.40 million	5.29	$28.80 million	$0.11	177.54

Mirion Technologies has higher revenue and earnings than SMX (Security Matters) Public.

Institutional & Insider Ownership

15.7% of SMX (Security Matters) Public shares are owned by institutional investors. Comparatively, 78.5% of Mirion Technologies shares are owned by institutional investors. 9.4% of SMX (Security Matters) Public shares are owned by company insiders. Comparatively, 2.2% of Mirion Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Volatility and Risk

SMX (Security Matters) Public has a beta of -2.4, meaning that its share price is 340% less volatile than the S&P 500. Comparatively, Mirion Technologies has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings for SMX (Security Matters) Public and Mirion Technologies, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SMX (Security Matters) Public	1	0	0	0	1.00
Mirion Technologies	0	2	7	1	2.90

Mirion Technologies has a consensus target price of $27.25, indicating a potential upside of 39.54%. Given Mirion Technologies’ stronger consensus rating and higher probable upside, analysts plainly believe Mirion Technologies is more favorable than SMX (Security Matters) Public.

Summary

Mirion Technologies beats SMX (Security Matters) Public on 11 of the 12 factors compared between the two stocks.

About SMX (Security Matters) Public

SMX (Security Matters) Public Limited Company, through its subsidiaries, engages in the development and commercialization of track and trace technologies for various industries. It owns and commercializes technology to mark various objects, such as solid, liquid, or gas allowing identification, circularity, proof of authenticity, tracking supply chain movements, and quality assurance. The company's technology comprises a chemical-based hidden barcode system, as well as a reader to identify these codes and a blockchain record to store and protect ownership data. It serves brand owners and manufacturers. The company was formerly known as Empatan Public Limited Company and changed its name to SMX (Security Matters) Public Limited Company in February 2023. SMX (Security Matters) Public Limited Company was incorporated in 2022 and is based in Dublin, Ireland.

About Mirion Technologies

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.